Xconomy | Seattle - Business + Technology in the Exponential Economy

Related Posts

Biotech, deals, Parkinson's

Omeros Nabs Michael J. Fox Grant

Luke Timmerman 1/7/09

Omeros, a Seattle-based drug developer, said it has received a $465,000 grant from the Michael J. Fox Foundation for Parkinson’s Research. The grant will pay for research of a new target on brain cells discovered by Omeros scientists, which has been linked to movement disorders like Parkinson’s and Restless Leg Syndrome.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.